During the past decade, Mid Kent Oncology Centre at Maidstone Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 11 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mid Kent Oncology Centre at Maidstone Hospital" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "ETOP IBCSG Partners Foundation" with 3 trials sponsored, "Royal Marsden NHS Foundation Trust" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Cambridge University Hospitals NHS Foundation Trust" with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mid Kent Oncology Centre at Maidstone Hospital" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Roche Pharma AG" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Mid Kent Oncology Centre at Maidstone Hospital" are "Colorectal Cancer" (7 trials), "Breast Cancer" (6 trials), "Ovarian Cancer" (6 trials), "Fallopian Tube Cancer" (4 trials) and "Lymphoma" (3 trials). Many other conditions were trialed in "Mid Kent Oncology Centre at Maidstone Hospital" in a lesser frequency.

Most popular intervention types in "Mid Kent Oncology Centre at Maidstone Hospital" are "Drug" (39 trials), "Other" (9 trials), "Procedure" (8 trials), "Biological" (7 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "quality-of-life assessment" (6 trials), "Cyclophosphamide" (4 trials), "Atezolizumab" (3 trials), "Bevacizumab" (3 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Mid Kent Oncology Centre at Maidstone Hospital" are 39 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Mid Kent Oncology Centre at Maidstone Hospital". 1 are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Mid Kent Oncology Centre at Maidstone Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mid Kent Oncology Centre at Maidstone Hospital, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".